Cowen Starts Kite Pharma (KITE) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
Go back to Cowen Starts Kite Pharma (KITE) at Outperform
July 15, 2014 7:46 AM EDT
Credit Suisse initiated coverage on Kite Pharma (NASDAQ: KITE) with an Outperform rating and a price target of $34.00.
Analyst Jason Kantor expressed enthusiasm for the CAR T and immuno-oncology space and the company's unique position in the field and fast-to-market strategy. Lead therapy,... More
July 15, 2014 7:44 AM EDT
Stifel Nicolaus initiated coverage on Kite Pharma (NASDAQ: KITE) with a Buy rating and a price target of $31.00.
For an analyst ratings summary and ratings history on Kite Pharma click here. For more ratings news on Kite Pharma click here.
Shares of Kite Pharma closed at $24.05 yesterday.
...
More
July 15, 2014 6:41 AM EDT
Jefferies initiates coverage on Kite Pharma (NASDAQ: KITE) with a Buy rating and a price target of $35.00.
Analyst Biren Amin comments, "KITE shares hold significant promise based on PI/II data with KTE-C19 observing robust responses in... More
